Gojayeva G, Tekin G, Saruhan Kose N, Dereci O, Kosar YC, Caliskan G (2024) Evaluation of complications and quality of life of patient after surgical extraction of mandibular impacted third molar teeth. BMC Oral Health 24(1):131. https://doi.org/10.1186/s12903-024-03877-8
Article PubMed PubMed Central Google Scholar
Barone S, Bennardo F, Salviati M, Antonelli A, Giudice A (2025) Evaluation of the usefulness of platelet-rich fibrin (PRF) in mandibular third molar surgery with 3D facial swelling analysis: a split-mouth randomized clinical trial. Head Face Medicine 21(1):8. https://doi.org/10.1186/s13005-025-00482-0
Article CAS PubMed PubMed Central Google Scholar
Peñarrocha-Diago M, Camps-Font O, Sánchez-Torres A, Figueiredo R, Sánchez-Garcés MA, Gay-Escoda C (2021) Indications of the extraction of symptomatic impacted third molars. A systematic review. J Clin Exp Dent 13(3):e278–e286. https://doi.org/10.4317/jced.56887
Article PubMed PubMed Central Google Scholar
Christensen K, Daniels S, Bandy D, Ernst CC, Hamilton DA, Mermelstein FH, Wang J, Carr DB (2011) A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesth Prog 58(2):73–81. https://doi.org/10.2344/0003-3006-58.2.73
Article PubMed PubMed Central Google Scholar
Nørholt SE, Sindet-Pedersen S, Bugge C, Branebjerg PE, Ersbøll BK, Bastian HL (1995) A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars. J Clin Pharmacol 35(6):606–614. https://doi.org/10.1002/j.1552-4604.1995.tb05018.x
Olmedo MV, Gálvez R, Vallecillo M (2001) Double-blind parallel comparison of multiple doses of ketorolac, ketoprofen and placebo administered orally to patients with postoperative dental pain. Pain 90(1–2):135–141. https://doi.org/10.1016/s0304-3959(00)00396-1
Article CAS PubMed Google Scholar
Varvara G, Bernardi S, Cutilli T, Bianchi S, Sinjari B, Piattelli M (2017) Anti-inflammatory steroid use in impacted third molar surgery: a systematic review. J Biol Regul Homeost Agents 31(4):1095–1099
Janarthanan K, Adalarasan S (2019) Cox-2 inhibitors in mandibular third molar surgery. J Med Life 12(2):150–155. https://doi.org/10.25122/jml-2019-0007
Article CAS PubMed PubMed Central Google Scholar
Pergolizzi JV, Breve F, Magnusson P, LeQuang JK, Varassi G (2023) Current and emerging COX inhibitors for treating postoperative pain following oral surgery. Expert Opin Pharmacother 24(3):347–358. https://doi.org/10.1080/14656566.2022.2161364
Article CAS PubMed Google Scholar
Cicconetti A, Bartoli A, Ripari F, Ripari A (2004) COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(2):139–146. https://doi.org/10.1016/j.tripleo.2003.08.032
Bindu S, Mazumder S, Bandyopadhyay U (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol 180:114147. https://doi.org/10.1016/j.bcp.2020.114147
Article CAS PubMed PubMed Central Google Scholar
Arfeen M, Srivastava A, Srivastava N, Khan RA, Almahmoud SA, Mohammed HA (2024) Design, classification, and adverse effects of nsaids: A review on recent advancements. Bioorg Med Chem 112:117899. https://doi.org/10.1016/j.bmc.2024.117899
Article CAS PubMed Google Scholar
Tai FWD, McAlindon ME (2021) Non-steroidal anti-inflammatory drugs and the Gastrointestinal tract. Clin Med (Lond) 21(2):131–134. https://doi.org/10.7861/clinmed.2021-0039
Dalpiaz AS, Peterson D (2004) Parecoxib: a shift in pain management? Expert Rev Neurother 4(2):165–177. https://doi.org/10.1586/14737175.4.2.165
Article CAS PubMed Google Scholar
Amabile CM, Spencer AP (2004) Parecoxib for parenteral analgesia in postsurgical patients. Ann Pharmacother 38(5):882–886. https://doi.org/10.1345/aph.1D283
Article CAS PubMed Google Scholar
Chen M, Sun W, Wang Z, Huang C, Hu G, Chen Y, Wang L (2020) Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies. BMC Pharmacol Toxicol 21(1):27. https://doi.org/10.1186/s40360-020-00406-5
Article CAS PubMed PubMed Central Google Scholar
Giorgi M, Saccomanni G, Del Carlo S, Manera C, Lavy E (2012) Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles. Vet J 193(1):246–250. https://doi.org/10.1016/j.tvjl.2011.11.005
Article CAS PubMed Google Scholar
Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC (2001) A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 23(7):1018–1031. https://doi.org/10.1016/s0149-2918(01)80088-6
Article CAS PubMed Google Scholar
Desjardins PJ, Grossman EH, Kuss ME et al (2001) The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 93(3):721–727. https://doi.org/10.1097/00000539-200109000-00036
Article CAS PubMed Google Scholar
Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC (2003) Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery. J Oral Maxillofac Surg 61(9):1030–1037. https://doi.org/10.1016/s0278-2391(03)00315-x
Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC (2004) The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. J Am Dent Assoc 135(11):1578–1590. https://doi.org/10.14219/jada.archive.2004.0085
Article CAS PubMed Google Scholar
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65–94
Higgins JP, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Oxford. http://www.cochranehandbook.org
Leonardo R (2018) PICO: model for clinical questions. Evid Based Med Pract 3:2
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
Article PubMed PubMed Central Google Scholar
Sung JM, Kim JY, Kwon BS, Kim KN (2023) Risk of bias for randomized controlled trials in journal of clinical monitoring and computing. J Clin Monit Comput 37(1):103–111
Jones A, Steel D (2018) Evaluating the quality of medical evidence in real-world contexts. J Eval Clin Pract 24(5):950–956
Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S et al (2004) Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE working group. BMC Health Serv Res 4(1):38
Article PubMed PubMed Central Google Scholar
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926
Article PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Comments (0)